INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2022

A guideline recommends 400 to 600 mg/d of dietary flavan-3-ols from food to support cardiometabolic health.

An Expert Panel developed a food-based intake recommendation for flavan-3-ols based on a review of 157 randomized controlled trials and 15 cohort studies using the Academy of Nutrition and Dietetics Evidence to Decision Framework. Moderate evidence supported cardiometabolic protection from dietary flavan-3-ol intake in the range of 400-600 mg/d. Increasing dietary intake was found to improve blood pressure, cholesterol levels, and blood sugar, with the strongest evidence for systolic blood pressure, total cholesterol, HDL cholesterol, and insulin/glucose dynamics. This recommendation is food-based and not intended for supplements.

Study type
Evidence-based dietary guideline
Who was studied
Evidence base of 157 randomized controlled trials and 15 cohort studies
What was measured
Cardiometabolic outcomes including blood pressure, cholesterol, and blood sugar

THE PAPER

Flavan-3-ols and Cardiometabolic Health: First Ever Dietary Bioactive Guideline.

Crowe-White KM, Evans LW, Kuhnle GGC, Milenkovic D, Stote K, Wallace T, Handu D, Senkus KE. Adv Nutr, 2022.

PubMed 36190328 ↗DOI 10.1093/advances/nmac105 ↗

Heart & arteriesDiabetes & blood sugarBlood pressureNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.